tradingkey.logo

tradingkey.logo
怜玢


Sophia Genetics SA

SOPH
りォッチリストに远加
7.890USD
+0.020+0.25%
取匕時間 10/29, 15:39ET
671.68M時䟡総額
損倱額盎近12ヶ月PER

Sophia Genetics SAに぀いお 䌁業名

SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.

Sophia Genetics SA プロフィヌル


䌁業コヌドSOPH
䌚瀟名SOPHiA GENETICS SA
䞊堎日Jul 23, 2021
最高経営責任者「CEO」Camblong (Jurgi)
埓業員数423
蚌刞皮類Ordinary Share
決算期末Jul 23
本瀟所圚地La Piece 12
郜垂ROLLE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Switzerland
郵䟿番号CH-1180
電話番号41216941060
りェブサむトhttps://www.sophiagenetics.com/
䌁業コヌドSOPH
䞊堎日Jul 23, 2021
最高経営責任者「CEO」Camblong (Jurgi)

Sophia Genetics SAの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.76M
-1.76%
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.76M
-1.76%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
605.52K
-1.62%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
605.52K
-1.62%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
428.40K
-2.66%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
428.40K
-2.66%
Mr. Troy M. Cox
Mr. Troy M. Cox
Independent Director
Independent Director
294.96K
+6.69%
Mr. Troy M. Cox
Mr. Troy M. Cox
Independent Director
Independent Director
294.96K
+6.69%
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.76M
-1.76%
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.76M
-1.76%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
605.52K
-1.62%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
605.52K
-1.62%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%

よくある質問

Sophia Genetics SAの䞊䜍5名の株䞻は誰ですか


Sophia Genetics SAの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Jurgi Camblong, Ph.D.

Sophia Genetics SASOPHの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Sophia Genetics SAの株匏を保有しおいる機関は89瀟あり、保有株匏の総垂堎䟡倀は玄27.73Mで、党䜓の38.63%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-11894064.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。